MALIGNANT SOFT TISSUE NEOPLASM

MALIGNANT SOFT TISSUE NEOPLASM was reported 12 times

MALIGNANT SOFT TISSUE NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 3 0.0014
1 Estrogen Receptor Antagonist [EPC] 1 0.0000
2 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
3 Interferon beta [EPC] 2 0.0000
4 Aromatase Inhibitor [EPC] 1 0.0000
5 Azole Antifungal [EPC] 1 0.0000
6 Alkylating Drug [EPC] 1 0.0000
7 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
8 beta-Adrenergic Blocker [EPC] 1 0.0000
9 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
10 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
11 Corticosteroid [EPC] 1 0.0000
12 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000